PHARMACORP RX INC (PCRX.CA) Stock Analyst Ratings

TSX-V:PCRX • CA71714X1050

0.45 CAD
0 (0%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to PCRX.CA. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 0.66. This target is 47.33% above the current price.
  • PCRX.CA was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about PCRX.CA.
  • Only 5 analysts analyzed PCRX.CA. So this is just the average opinion of a couple of analysts.

Related screens

Find peers with buy consensus above 85%
PCRX.CA Historical Analyst RatingsPCRX.CA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating 0 1 2 3 4

Price Target & Forecast

Price Low Median Mean High 0.450.660.660.660.68 - 45.89% 47.33% 47.33% 51.67%

Related screens

Find peers 30% below price target
PCRX.CA Current Analyst RatingPCRX.CA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades

PHARMACORP RX INC / PCRX.CA FAQ

What is the average price target for PHARMACORP RX INC (PCRX.CA) stock?

5 analysts have analysed PCRX.CA and the average price target is 0.66 CAD. This implies a price increase of 47.33% is expected in the next year compared to the current price of 0.45.


Can you provide the consensus rating for PHARMACORP RX INC stock?

The consensus rating for PHARMACORP RX INC (PCRX.CA) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.